Community Update: Votoplam data from long-term extention study (Phase 2 LTE)katie8288Apr 280 min read
Teva Presents New Data on AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® (deutetrabenazine) extended-release tablets that Show Patient- and Caregiver-Reported Improvements in Huntington's Disease
Looking Forward Together: An Open Letter from the Huntington's Disease Advocacy Community to the White House
Comments